Cell ReportsCancer BiologyPeer-reviewed journal article
Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in melanoma.
Diogo DiasiD, Erica Aparecida de OliveiraiD, Román Martí-DíaziD, Sarah Andrews, Ana Chocarro‐CalvoiD, Alice Bellini, Laura MosteoiD, Yurena VivasiD, Jagat Singh ChauhaniD, Linxin LiiD, José Manuel García-MartíneziD, José Neptuno Rodríguez‐LópeziD, Silvya Stuchi Maria–EngleriD, Colin KennyiD, Javier Martínez‐UserosiD, Custodia García‐JiméneziD, Luís Sánchez‐del‐CampoiD, Pakavarin LouphrasitthipholiD, Colin R. GodingiD
- Citations
- 7
- FWCI
- 1.93
- Field percentile
- top 13%
Abstract
Cells can contain multiple related transcription factors targeting the same sequences, leading to potential regulatory cooperativity, redundancy, competition or temporally regulated factor exchange. Yet the differential biological functions of co-targeting transcription factors are poorly understood. In melanoma, three highly related transcription factors are co-expressed: The mTORC1-regulated TFEB and TFE3, key effectors of a wide range of metabolic and microenvironmental cues assumed to perform similar functions; and MITF, that controls melanoma phenotypic identity. Here we reveal the functional specialization of MITF, TFE3 and TFEB and their impact on melanoma progression. Notably, although all bind the same sequences, each regulates different and frequently opposing gene expression programs to coordinate differentiation, metabolism, and protein synthesis, and qualitatively and quantitatively impact tumor immune infiltration. The results uncover a hierarchical cascade whereby microenvironmental stresses, including glucose limitation, lead MITF, TFEB and TFE3 to drive distinct biologically important transcription programs that underpin phenotypic transitions in cancer.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antagonistic Roles for MITF and TFE3 in Melanoma Plasticity
Jeremy Chang, Katelyn R. Campbell-Hanson, … Colin Kenny·Cell ReportsPeer-reviewed·Mar 26, 2025
- MITF reprograms the extracellular matrix and focal adhesion in melanoma
R. Dilshat, V. Fock, … E. Steingrimsson·bioRxiv·Jul 14, 2020
- The small MAF transcription factor MAFG co-opts MITF to promote melanoma progression
Olga Vera, Michael Martinez, … Florian A. Karreth·Nature CommunicationsPeer-reviewed·May 21, 2026
- STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pigmentation pathway
A. Swoboda, R. Soukup, … R. Moriggl·OncogenePeer-reviewed·Dec 15, 2020
- TFAP2 paralogs facilitate chromatin access for MITF at pigmentation genes but inhibit expression of cell-cell adhesion genes independently of MITF
Colin Kenny, Ramile Dilshat, … Robert A. Cornell·PLoS GeneticsPeer-reviewed·May 17, 2022
- Nuclear Transport Factor 2 (NTF2) suppresses metastatic melanoma by modifying cell migration, metastasis, and gene expression
L. D. Vukovic, K. H. White, … D. L. Levy·bioRxiv·Mar 13, 2020